BSX · Earnings call · 2026Q3T · Full report

Operating Income and Margins

BOSTON SCIENTIFIC CORP · 2026-10-28 · Importance 36 · Surprise 32

Q3 adjusted operating margin was 26.5%, contracting 150 basis points year over year, primarily because the cyber incident pressured gross margin. GAAP operating margin was 16.1% and included an approximately $80 million charge, primarily related to certain product liability cases. Full-year 2026 adjusted operating margin is expected to be approximately 27.6%, reflecting gross-margin pressures.

Key facts

• Boston Scientific expects FY2026 adjusted operating margin of approximately 27.6%, reflecting gross-margin pressures.
• Q3 2026 GAAP operating margin was 16.1%, including an approximately $80 million charge primarily related to certain product liability cases.
• Q3 2026 adjusted EPS was $0.73, down 3% versus the guidance range of $0.80 to $0.82.
• Q3 2026 adjusted operating margin was 26.5%, down 150 basis points year over year, primarily due to the cyber incident's gross-margin impact.